Source discipline
Future prices should come from identifiable, dated sources. No invented ranges.
Trust infrastructure
Research & Cost Methodology
How Angirx Review will source, calculate, update and qualify medication and treatment cost information.
Sources and verification
Angirx Review prioritizes current official sources for approval, generic status, Medicare rules and drug information. Pricing and coverage should still be verified for the exact pharmacy, plan, dose, quantity and date.
Frequently asked questions
How does Angirx Review calculate medication costs?
The methodology separates source price, dose, quantity, refill frequency, insurance assumptions and discount conditions. Monthly, annual and multi-year figures are derived only after those inputs are defined.
Why are medication prices shown as ranges or scenarios?
Prices vary by pharmacy, geography, insurance, benefit phase and date. Ranges and scenario calculations are more honest than one fixed number that appears universally precise.
How is an annual medication estimate calculated?
Use the current out-of-pocket or cash amount for the exact refill and multiply by the expected annual refill frequency. State whether deductibles, coupons, administration fees or monitoring are included.
How is a five-year medication estimate calculated?
Apply the current recurring cost to the expected number of refills over five years and label the result as a scenario. The methodology should explicitly warn that future prices, coverage and treatment plans can change.
How are insurance costs handled?
Insurance values should come from plan-specific tools or documents when available. Cash price, negotiated price and member out-of-pocket amount are kept distinct because they answer different questions.
How is Medicare information handled?
Medicare estimates should reference the user's Part D or Medicare Advantage plan, formulary and benefit rules. The methodology avoids claiming that one Medicare price applies to all beneficiaries.
How are coupons and manufacturer assistance treated?
They are separate scenarios with eligibility, expiration and restriction notes. Temporary assistance should not silently become the assumed price for a multi-year estimate.
How is generic availability verified?
Use current regulatory and pharmacy evidence. An approval can precede broad market availability, so the methodology distinguishes regulatory status from what a user can actually buy.
How often should source data be refreshed?
Refresh frequency depends on volatility. Prices, formularies and assistance programs need more frequent checking than stable background material. Every cost page should display a visible verification date.
How are conflicting sources handled?
Check whether the sources are measuring the same dose, quantity, pharmacy type, insurance context and date. When differences remain, present the range and explain the source conditions instead of arbitrarily selecting one number.
Can the methodology predict a patient's exact future spending?
No. It produces planning estimates from stated assumptions. Actual spending may differ because treatment, insurance, prices and healthcare needs change.
Why publish our methodology?
Transparent calculations, definitions, source dates and limitations make content easier to audit and extract correctly. That improves information quality for readers and for systems that retrieve or summarize the page.
Time-horizon calculations
Annual, 5-year and 10-year figures will use transparent arithmetic and clearly stated assumptions.
Insurance variability
Coverage and out-of-pocket costs vary by plan, location, dose and date.
Medical boundaries
Cost comparisons do not imply that therapies are clinically interchangeable.
Start with the cost categories relevant to you.
Use the Angirx Review assessment to organize medication, insurance, procedure and long-term treatment cost factors before using the full heart-disease cost calculator.
Take the Cost Assessment